Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, September 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 57 articles:
HTML format


 

Single Articles

  1. SIBELLI A, Chalder T, Everitt H, Workman P, et al
    The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study.
    Br J Health Psychol. 2017 Sep 1. doi: 10.1111/bjhp.12264.
    Abstract    

    Abstract available

  2. VOGT BA, Vogt LJ, Sikes RW
    A nociceptive stress model of adolescent physical abuse induces contextual fear and cingulate nociceptive neuroplasticities.
    Brain Struct Funct. 2017 Aug 31. doi: 10.1007/s00429-017-1502.
    Abstract    

    Abstract available

  3. KERN KU, Schwickert M
    Ambroxol for the treatment of fibromyalgia: science or fiction?
    J Pain Res. 2017;10:1905-1929.
    Abstract    

    Abstract available

  4. TOIVONEN KI, Zernicke K, Carlson LE
    Web-Based Mindfulness Interventions for People With Physical Health Conditions: Systematic Review.
    J Med Internet Res. 2017;19:e303.
    Abstract    

    Abstract available

  5. MARKOZANNES G, Aretouli E, Rintou E, Dragioti E, et al
    An umbrella review of the literature on the effectiveness of psychological interventions for pain reduction.
    BMC Psychol. 2017;5:31.
    Abstract    

    Abstract available

  6. ABDEL-AZIZ H, Kelber O, Lorkowski G, Storr M, et al
    Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.
    Planta Med. 2017 Aug 31. doi: 10.1055/s-0043-116852.
    Abstract    

    Abstract available

  7. CONG X, Perry M, Bernier KM, Young EE, et al
    Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.
    West J Nurs Res. 2017 Aug 1:193945917727705. doi: 10.1177/0193945917727705.
    Abstract    

    Abstract available

  8. BASHASHATI M, Moossavi S, Cremon C, Barbaro MR, et al
    Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis.
    Neurogastroenterol Motil. 2017 Aug 29. doi: 10.1111/nmo.13192.
    Abstract    

    Abstract available

  9. MAZZAWI T, El-Salhy M
    Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review).
    Int J Mol Med. 2017 Aug 11. doi: 10.3892/ijmm.2017.3096.
    Abstract    

    Abstract available

  10. ALTOBELLI E, Del Negro V, Angeletti PM, Latella G, et al
    Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  11. JANG SH, Ryu HS, Choi SC, Lee SY, et al
    Psychological Factors Influence the Irritable Bowel Syndrome and Their Effect on Quality of Life among Firefighters in South Korea.
    Psychiatry Investig. 2017;14:434-440.
    Abstract    

    Abstract available

  12. CONROY S, Hale MF, Cross SS, Swallow K, et al
    Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    J Clin Pathol. 2017 Aug 26. pii: jclinpath-2017-204506.
    Abstract    

    Abstract available

  13. BASHASHATI M, Moradi M, Sarosiek I
    Interleukin-6 in irritable bowel syndrome: A systematic review and meta-analysis of IL-6 (-G174C) and circulating IL-6 levels.
    Cytokine. 2017;99:132-138.
    Abstract    

    Abstract available

  14. CICHOWSKI SB, Rogers RG, Clark EA, Murata E, et al
    Military Sexual Trauma in Female Veterans is Associated With Chronic Pain Conditions.
    Mil Med. 2017;182:e1895-e1899.
    Abstract    

    Abstract available

  15. DUPLESSIS CA, Gutierrez RL, Porter CK
    Review: chronic and persistent diarrhea with a focus in the returning traveler.
    Trop Dis Travel Med Vaccines. 2017;3:9.
    Abstract    

    Abstract available

  16. SHAHDADI H, Balouchi A, Shaykh A
    Comparison of Resilience and Psychological Wellbeing in Women with Irritable Bowel Syndrome and Normal Women.
    Mater Sociomed. 2017;29:105-108.
    Abstract    

    Abstract available

  17. BUSCAIL C, Sabate JM, Bouchoucha M, Kesse-Guyot E, et al
    Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet Cohort.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  18. CURRIE SL, Stephenson N, Palmer AS, Jones BL, et al
    Under-reporting giardiasis: time to consider the public health implications.
    Epidemiol Infect. 2017 Sep 7:1-5. doi: 10.1017/S0950268817001959.
    Abstract    

    Abstract available

  19. IWANCZAK B, Iwanczak F
    [Functional gastrointestinal disorders in children and adolescents. The Rome IV criteria].
    Pol Merkur Lekarski. 2017;43:75-82.
    Abstract    

    Abstract available

  20. DIMIDI E, Rossi M, Whelan K
    Irritable bowel syndrome and diet: where are we in 2018?
    Curr Opin Clin Nutr Metab Care. 2017 Sep 1. doi: 10.1097/MCO.0000000000000416.
    Abstract    

    Abstract available

  21. LEE CE, Yong PJ, Williams C, Allaire C, et al
    Factors Associated with Severity of Irritable Bowel Syndrome Symptoms in Patients with Endometriosis.
    J Obstet Gynaecol Can. 2017 Sep 1. pii: S1701-2163(17)30089.
    Abstract    

    Abstract available

  22. STRUYF N, Laurent J, Verspreet J, Verstrepen KJ, et al
    Saccharomyces cerevisiae and Kluyveromyces marxianus co-cultures allow to reduce FODMAP levels in whole wheat bread.
    J Agric Food Chem. 2017 Sep 4. doi: 10.1021/acs.jafc.7b02793.
    Abstract    

    Abstract available

  23. RODE AA, Chehri M, Petersen AM, Bytzer P, et al
    [Faecal microbiota transplantation for the treatment of bowel disease].
    Ugeskr Laeger. 2017;179.
    Abstract    

    Abstract available

  24. ADLER AI
    NICE guidance on eluxadoline for treating irritable bowel syndrome with diarrhoea.
    Lancet Gastroenterol Hepatol. 2017 Aug 29. pii: S2468-1253(17)30267.
    Abstract    



  25. SHALOM G, Magen E, Babaev M, Horev A, et al
    Chronic Urticaria and Irritable Bowel Syndrome: a Cross-Sectional Study of 11,271 Patients.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15997.
    Abstract    

    Abstract available

  26. FACCIOLA A, Riso R, Avventuroso E, Visalli G, et al
    Campylobacter: from microbiology to prevention.
    J Prev Med Hyg. 2017;58:E79-E92.
    Abstract    

    Abstract available

  27. LANKARANI KB, Akbari M, Tabrizi R
    Association of Gastrointestinal Functional Disorders and Migraine Headache: a Population Base Study.
    Middle East J Dig Dis. 2017;9:139-145.
    Abstract    

    Abstract available

  28. GUPTA K, Ghuman HS, Handa SV
    Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile.
    Clin Med Insights Gastroenterol. 2017;10:1179552217728905.
    Abstract    

    Abstract available

  29. PANEK-JEZIORNA M, Mulak A
    The role of bile acids in the pathogenesis of bowel diseases.
    Postepy Hig Med Dosw (Online). 2017;71:737-746.
    Abstract    

    Abstract available

  30. LIS DM, Stellingwerff T, Kitic CM, Fell JW, et al
    Low FODMAP: A Preliminary Strategy to Reduce Gastrointestinal Distress in Athletes.
    Med Sci Sports Exerc. 2017 Sep 7. doi: 10.1249/MSS.0000000000001419.
    Abstract    

    Abstract available

  31. JALANKA J, Spiller R
    Role of microbiota in the pathogenesis of functional disorders of the lower GI tract: Work in progress.
    Neurogastroenterol Motil. 2017;29:1-5.
    Abstract    

    Abstract available

  32. MERTSALMI TH, Aho VTE, Pereira PAB, Paulin L, et al
    More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
    Eur J Neurol. 2017 Sep 11. doi: 10.1111/ene.13398.
    Abstract    

    Abstract available

  33. QUIGLEY EMM
    Prokinetics in the Management of Functional Gastrointestinal Disorders.
    Curr Gastroenterol Rep. 2017;19:53.
    Abstract    

    Abstract available

  34. MOSER G, Fournier C, Peter J
    Intestinal microbiome-gut-brain axis and irritable bowel syndrome.
    Wien Med Wochenschr. 2017 Sep 8. doi: 10.1007/s10354-017-0592.
    Abstract    

    Abstract available

  35. DIDUCH BK
    Gastrointestinal Conditions in the Female Athlete.
    Clin Sports Med. 2017;36:655-669.
    Abstract    

    Abstract available

  36. AMNUAYCHEEWA P, Murray JA, Marietta EV
    Animal models to study non-celiac gluten sensitivity.
    Minerva Gastroenterol Dietol. 2017;63:22-31.
    Abstract    

    Abstract available

  37. PAZMANY E, Ly HG, Aerts L, Kano M, et al
    Brain responses to vestibular pain and its anticipation in women with Genito-Pelvic Pain/Penetration Disorder.
    Neuroimage Clin. 2017;16:477-490.
    Abstract    

    Abstract available

  38. CORSETTI M, Whorwell P
    The global impact of IBS: time to think about IBS-specific models of care?
    Therap Adv Gastroenterol. 2017;10:727-736.
    Abstract    

    Abstract available

  39. LEVIO S, Cash BD
    The place of eluxadoline in the management of irritable bowel syndrome with diarrhea.
    Therap Adv Gastroenterol. 2017;10:715-725.
    Abstract    

    Abstract available

  40. CASH BD, Pimentel M, Rao SSC, Weinstock L, et al
    Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Therap Adv Gastroenterol. 2017;10:689-699.
    Abstract    

    Abstract available

  41. DELGADO-HERRERA L, Lasch K, Zeiher B, Lembo AJ, et al
    Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.
    Therap Adv Gastroenterol. 2017;10:673-687.
    Abstract    

    Abstract available

  42. MAO Y, Li Z, Chen K, Yu H, et al
    Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
    Cell Physiol Biochem. 2017;43:518-530.
    Abstract    

    Abstract available

  43. WHITE JF
    Syntrophic imbalance and the etiology of bacterial endoparasitism diseases.
    Med Hypotheses. 2017;107:14-15.
    Abstract    

    Abstract available

  44. VAN DEN HOUTE M, Bogaerts K, Van Diest I, De Bie J, et al
    Inducing somatic symptoms in functional syndrome patients: Effects of manipulating state negative affect.
    Psychosom Med. 2017 Sep 13. doi: 10.1097/PSY.0000000000000527.
    Abstract    

    Abstract available

  45. BECKERS AB, Weerts ZZRM, Helyes Z, Masclee AAM, et al
    Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Sep 8. doi: 10.1111/apt.14294.
    Abstract    

    Abstract available

  46. BLACK CJ, Ford AC
    Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation?
    Aliment Pharmacol Ther. 2017;46:697.
    Abstract    



  47. POLSTER A, Van Oudenhove L, Jones M, Ohman L, et al
    Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.
    Aliment Pharmacol Ther. 2017;46:698-699.
    Abstract    



  48. CRYER B, Drossman DA, Chey WD, Webster L, et al
    Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders.
    Dig Dis Sci. 2017 Aug 28. doi: 10.1007/s10620-017-4680.
    Abstract    

    Abstract available

  49. PIMENTEL M, Cash BD, Lembo A, Wolf RA, et al
    Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4729.
    Abstract    



  50. SIECZKOWSKA A, Landowski P, Zagozdzon P, Kaminska B, et al
    The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000946.
    Abstract    



  51. GIBSON PR, Burgell R
    Easing Concerns About the Low FODMAP Diet in Patients With Irritable Bowel Syndrome.
    Gastroenterology. 2017 Sep 1. pii: S0016-5085(17)36088.
    Abstract    



  52. DOWNS IA, Aroniadis OC, Kelly L, Brandt LJ, et al
    Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease.
    J Clin Gastroenterol. 2017 Sep 6. doi: 10.1097/MCG.0000000000000924.
    Abstract    

    Abstract available

  53. GWEE KA, Ghoshal UC, Chen M
    Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology and management.
    J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1111/jgh.13987.
    Abstract    

    Abstract available

  54. HARVIE R, Walmsley R, Schultz M
    "We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions.
    J Gastroenterol Hepatol. 2017;32:352-357.
    Abstract    

    Abstract available

  55. EL-SALHY M, Patcharatrakul T, Hatlebakk JG, Hausken T, et al
    Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
    Scand J Gastroenterol. 2017 Aug 30:1-9. doi: 10.1080/00365521.2017.1371793.
    Abstract    

    Abstract available

  56. CHUA CS, Bai CH, Shiao CY, Hsu CY, et al
    Negative correlation of cortical thickness with the severity and duration of abdominal pain in Asian women with irritable bowel syndrome.
    PLoS One. 2017;12:e0183960.
    Abstract    

    Abstract available

  57. TSENG CW, Lin CL, Chen YT, Jeng LB, et al
    Ischemic Bowel Syndrome in Patients with Spinal Cord Injury: A Nationwide Study.
    PLoS One. 2017;12:e0169070.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;